BIOPHYTIS S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.69 EUR | -1.41% |
|
+1.47% | -66.18% |
| May. 14 | Biophytis unveils design for obesity study | CF |
| May. 14 | Biophytis SA Announces the Design of its Phase 2 OBA Clinical Study in Obesity | CI |
| Sales 2024 * | - | Sales 2025 * | 4.8M 5.21M | Capitalization | 1.97M 2.14M |
|---|---|---|---|---|---|
| Net income 2024 * | -19M -20.61M | Net income 2025 * | -16M -17.35M | EV / Sales 2024 * | - |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.41 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | 22 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 40.58% |
More Fundamentals
* Assessed data
| 1 day | -1.41% | ||
| 1 week | +1.47% | ||
| 1 month | -17.86% | ||
| 3 months | -58.93% | ||
| 6 months | -69.74% | ||
| Current year | -66.18% |
1 week
0.67
0.78
1 month
0.630.96
Current year
0.632.24
1 year
0.6312.80
3 years
0.63423.80
5 years
0.631 092.00
10 years
0.637 720.00
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 0.69 | -1.41% | 18,656 |
| 24-05-30 | 0.6999 | -4.12% | 43,018 |
| 24-05-29 | 0.73 | -.--% | 10,235 |
| 24-05-28 | 0.73 | +6.12% | 19,688 |
| 24-05-27 | 0.6879 | +1.16% | 21,178 |
Real-time Euronext Paris, May 31, 2024 at 11:12 am EDT
More quotes
Biophytis S.A. is a biotechnology company in the clinical stage specialized in the development of drug candidates to slow degenerative processes and improve functional capacity in patients with age-related diseases, including respiratory failure in patients suffering from COVID-19.
The company is located in Paris, France and Cambridge, Massachusetts.
Calendar
2024-10-28
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -66.18% | 2.14M | |
| +11.91% | 118B | |
| +11.60% | 106B | |
| -4.68% | 24.28B | |
| -0.82% | 21.96B | |
| -10.12% | 18.16B | |
| -42.12% | 16.37B | |
| -17.47% | 15.56B | |
| +2.77% | 13.63B | |
| +34.58% | 12.27B |
- Stock Market
- Equities
- ALBPS Stock
